Letermovir for difficult to treat cytomegalovirus infection in lung transplant recipients

Background:Cytomegalovirus (CMV)-infection remains a major cause of morbidity and mortality after lung transplantation. Treatment with currently available drugs poses treatment difficulties in some patients due to drug resistance or intolerability.Methods:We report a series of four lung transplant r